Teva Reaches $225 Million Settlement with Texas Over Opioid Claims
On Monday, February 14, 2022, Texas Attorney General Ken Paxton announced a $225 million settlement with Teva Pharmaceutical…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
NEW
Pharmacists’ Role to Expand Over the Next Decade
According to recent research from the Columbia University Mailman School of Public Health and Express Scripts Pharmacy,…
MedPAC Presents MA Findings, Including Increased Spending
In mid-January 2022, MedPAC held its public meeting virtually via GoToWebinar, where the Commission covered a multitude of topics,…
Ten Individual Indicted in $300 Million Healthcare Fraud
Earlier this year, Chad E. Meacham, United States Attorney for the Northern District of Texas, announced a $300 million healthcare…
Diagnostic Company Reaches False Claims Act Settlement
In mid-February 2022, American Health Associates, Inc. (AHA) reached an agreement with the United States Department of Justice…
OPDP Sends “Bad Ad” Warning Letter over PARAGARD Video
On February 12, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a…
California Court Rules that FMV Payments Can Qualify as Illegal Kickbacks
On February 23, 2022, the United States District Court for the Central District of California denied Medtronic’s motion to dismiss…
Mallinckrodt Reaches $260 Million Anti-Kickback Settlement
Recently, Mallinckrodt ARD LLC reached a $260 million settlement to resolve allegations that Mallinckrodt violated the False…
Connecticut Governor Proposes Price Restrictions on Prescription Drugs
Earlier this year, Connecticut Governor Ned Lamont proposed to set a maximum price on prescription drugs, drawing criticism from…
CME Webinar Series Guides Clinicians on Individualizing HER2-Positive…
Despite significant improvement in the treatment of HER2-positive metastatic breast cancer in recent years, breast cancer remains…